Previous Article | Next Article ![]()
Journal of Clinical Microbiology, Mar 1997, 591-595, Vol 35, No. 3
SO Angel, M Matrajt, J Margarit, M Nigro, E Illescas, V Pszenny, MR Amendoeira, E Guarnera and JC Garberi
We report the potential use of a specific Toxoplasma gondii DNA probe
(ABGTg7). We applied a dot blot hybridization assay to blood samples for
the diagnosis of cerebral toxoplasmosis (CT), acute toxoplasmic
lymphadenopathy (ATL), and disseminated toxoplasmosis in transplant
recipients (TRs). We studied a total of 84 individuals: 38 patients and 46
controls. We found positive hybridization signals for 12 (66.7%) of 18
patients with confirmed CT, 9 (52.9%) of 17 patients with ATL, and 2
(66.7%) of 3 TRs. PCR assays were performed in parallel for patients with
ATL, resulting in T. gondii DNA detection for 10 patients (58.8%). A
comparative study between dot blot and PCR assays performed with the blood
of mice that had been experimentally infected with tachyzoites gave similar
results: 60 and 70% positive results, respectively. Finally, the sum of
positive values obtained by both DNA tests (dot blot assay plus PCR)
increased the rate of positivity for ATL patients to 76.4%. These results
demonstrate that the T. gondii ABGTg7 repetitive DNA element is an
additional useful resource for diagnosing Toxoplasma parasitemia in
patients with CT and ATL and in TRs. Thus, our ABGTg7-based dot blot test
may lead to an improvement in T. gondii detection methods in patients with
acute toxoplasmosis.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Screening for active toxoplasmosis in patients by DNA hybridization with the ABGTg7 probe in blood samples
Departamento Parasitologia, Instituto Nacional de Microbiologia Dr. Carlos G. Malbran, CP 1281, Buenos Aires, Argentina.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|